Paxalisib

GDC-0084 · Kazia Therapeutics Limited

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for Paxalisib, covering 2025-03-24 to 2026-02-05. Get the full timeline:

Most recent: Clinical Trial Update: 5G-PEARL: Paxalisib in Malignant Brain Tumours [Phase 1, Phase 2]